These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38377061)

  • 1. A deep-well plate enabled automated high-throughput cell line development platform.
    Tang X; Quiroz J; Zhang Y; Pan J; Lai Z; Du Z; Liu R
    Biotechnol Prog; 2024; 40(3):e3442. PubMed ID: 38377061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-throughput screening of antibody-expressing CHO clones using an automated shaken deep-well system.
    Wang B; Albanetti T; Miro-Quesada G; Flack L; Li L; Klover J; Burson K; Evans K; Ivory W; Bowen M; Schoner R; Hawley-Nelson P
    Biotechnol Prog; 2018 Nov; 34(6):1460-1471. PubMed ID: 30298994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustaining an efficient and effective CHO cell line development platform by incorporation of 24-deep well plate screening and multivariate analysis.
    Mora A; Zhang SS; Carson G; Nabiswa B; Hossler P; Yoon S
    Biotechnol Prog; 2018 Jan; 34(1):175-186. PubMed ID: 29150912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microarray platform affords improved product analysis in mammalian cell growth studies.
    Datta P; Meli L; Li L; Migliore N; Schaefer E; Sharfstein ST; Dordick JS; Linhardt RJ
    Biotechnol J; 2014 Mar; 9(3):386-395. PubMed ID: 24227746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent transfection of randomized transgene configurations into targeted integration CHO host is an advantageous and cost-effective method for expression of complex molecules.
    Dong E; Lam C; Tang D; Louie S; Yim M; Williams AJ; Sawyer W; Yip S; Carver J; AlBarakat A; Tsukuda J; Snedecor B; Misaghi S
    Biotechnol J; 2021 Apr; 16(4):e2000230. PubMed ID: 33259700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration of high-throughput analytics and cell imaging enables direct early productivity and product quality assessment during Chinese Hamster ovary cell line development for a complex multi-subunit vaccine antigen.
    Li X; Zhang Y; Jing L; Fu Z; Ma O; Ganguly J; Vaidya N; Sisson R; Naginskaya J; Chinthala A; Cui M; Yamagata R; Wilson M; Sanders M; Wang Z; Lo Surdo P; Bugno M
    Biotechnol Prog; 2020 Mar; 36(2):e2914. PubMed ID: 31568688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of a novel cell line, CHO-MK, derived from Chinese hamster ovary tissues for biologics manufacturing.
    Masuda K; Kubota M; Nakazawa Y; Iwama C; Watanabe K; Ishikawa N; Tanabe Y; Kono S; Tanemura H; Takahashi S; Makino T; Okumura T; Horiuchi T; Nonaka K; Murakami S; Kamihira M; Omasa T
    J Biosci Bioeng; 2024 Jun; 137(6):471-479. PubMed ID: 38472071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automated and enhanced clone screening using a fully automated microtiter plate-based system for suspension cell culture.
    Markert S; Musmann C; Hülsmann P; Joeris K
    Biotechnol Prog; 2019 Mar; 35(2):e2760. PubMed ID: 30506896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput and automation advances for accelerating single-cell cloning, monoclonality and early phase clone screening steps in mammalian cell line development for biologics production.
    Tejwani V; Chaudhari M; Rai T; Sharfstein ST
    Biotechnol Prog; 2021 Nov; 37(6):e3208. PubMed ID: 34478248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration of cell line and process development to overcome the challenge of a difficult to express protein.
    Alves CS; Gilbert A; Dalvi S; St Germain B; Xie W; Estes S; Kshirsagar R; Ryll T
    Biotechnol Prog; 2015; 31(5):1201-11. PubMed ID: 25919541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A high-throughput automated platform for the development of manufacturing cell lines for protein therapeutics.
    Shi S; Condon RG; Deng L; Saunders J; Hung F; Tsao YS; Liu Z
    J Vis Exp; 2011 Sep; (55):. PubMed ID: 21968840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of cell line development in the GS-CHO expression system using a high-throughput, single cell-based clone selection system.
    Nakamura T; Omasa T
    J Biosci Bioeng; 2015 Sep; 120(3):323-9. PubMed ID: 25792187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An automated, low volume, and high-throughput analytical platform for aggregate quantitation from cell culture media.
    Lambiase G; Klottrup-Rees K; Lovelady C; Ali S; Shepherd S; Muroni M; Lindo V; James DC; Dickman MJ
    J Chromatogr A; 2023 Feb; 1691():463809. PubMed ID: 36731329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platform development for high-throughput optimization of perfusion processes: Part I: Implementation of cell bleeds in microwell plates.
    Dorn M; Klottrup-Rees K; Lee K; Micheletti M
    Biotechnol Bioeng; 2024 Jun; 121(6):1759-1773. PubMed ID: 38393309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing recombinant protein expression during CHO pool selection enhances frequency of high-producing cells.
    Poulain A; Mullick A; Massie B; Durocher Y
    J Biotechnol; 2019 Apr; 296():32-41. PubMed ID: 30885656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilizing targeted integration CHO pools to potentially accelerate the GMP manufacturing of monoclonal and bispecific antibodies.
    Barnard GC; Zhou M; Shen A; Yuk IH; Laird MW
    Biotechnol Prog; 2024; 40(1):e3399. PubMed ID: 37874920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced cell culture performance using inducible anti-apoptotic genes E1B-19K and Aven in the production of a monoclonal antibody with Chinese hamster ovary cells.
    Figueroa B; Ailor E; Osborne D; Hardwick JM; Reff M; Betenbaugh MJ
    Biotechnol Bioeng; 2007 Jul; 97(4):877-92. PubMed ID: 17099908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of a fully automated microtiter plate-based system for suspension cell culture and its application for enhanced process optimization.
    Markert S; Joeris K
    Biotechnol Bioeng; 2017 Jan; 114(1):113-121. PubMed ID: 27399304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. When will we have a clone? An industry perspective on the typical CLD timeline.
    Clarke H; Mayer-Bartschmid A; Zheng C; Masterjohn E; Patel F; Moffat M; Wei Q; Liu R; Emmins R; Fischer S; Rieder S; Kelly T
    Biotechnol Prog; 2024; 40(4):e3449. PubMed ID: 38477447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miRNA engineering of CHO cells facilitates production of difficult-to-express proteins and increases success in cell line development.
    Fischer S; Marquart KF; Pieper LA; Fieder J; Gamer M; Gorr I; Schulz P; Bradl H
    Biotechnol Bioeng; 2017 Jul; 114(7):1495-1510. PubMed ID: 28262952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.